Novo Nordisk A/S buy Luise1
Summary
This prediction ended on 10.12.14 with a price of €37.56. The prediction had a final performance of 14.59%. Luise1 has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
Comments by Luise1 for this prediction
In the thread Novo Nordisk A/S diskutieren
Älter und Fetter
Achtung Aktien Rückkaufprogramm beim Weltmarktführer....
update vom 01.09.14: ein champion für jedes konservative depot, kurszielerhöhung auf 40€ in nächsten 12 monaten
update vom 10.11.14: ruhig blut...nachkaufen ist oberstes gebot, der dänische riese wird es dir zurückzahlen!
Stopped prediction by Luise1 for Novo Nordisk A/S
Novo Nordisk A/S
14.09.19
04.11.21
05.11.21